Extracorporeal photopheresis in refractory chronic graft-versus-host disease: The influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology

Autor: Tsirigotis, Panagiotis Kapsimalli, Violetta Baltadakis, Ioannis and Kaloyannidis, Panayotis Karakasis, Dimitrios Papalexandri, Apostolia Psarra, Ekaterini Nosi, Efi Konsta, Evi and Vikentiou, Myrofora Papageorgiou, Sotirios Sakellari, Ioanna and Pappa, Vassiliki Harhalakis, Nikolaos Anagnostopoulos, Achilles and Dervenoulas, John
Jazyk: angličtina
Rok vydání: 2012
Popis: Extracorporeal photopheresis (ECP) has been established as an effective treatment modality for patients with chronic extensive graft-versus host disease (GVHD). In the present study, we evaluated the influence of ECP on the numbers of CD4(+), CD8(+), CD20(+), CD56(+) cells, and on T-regulatory (Tregs), as well as on the numbers of naive, central memory (CM), and effector memory (EM) T-cells in patients treated for refractory chronic GVHD. Flow cytometric analysis of peripheral blood lymphocytes was performed for the calculation of the different T-cell subsets. Patients with GVHD had a higher percentage of EM-CD4(+) cells in comparison with healthy donors (p = 0.046). The percentages of naive-CD8(+), naive-CD4(+), CM-CD8(+), CM-CD4(+), EM-CD8(+), and Tregs were not different between patients with GVHD and healthy donors. Similarly there was no statistical difference in the percentages of naive, CM, and EM CD4(+) and CD8(+) cells before and after 3 months of treatment with ECP. However, in the subset of Tregs a statistically significant increase was observed after 3 months of treatment with ECP (p = 0.015). Responders to ECP had statistically significantly higher absolute numbers of CD4(+), and CD8(+) cells, in comparison with non-responders. These data further support the concept that ECP does not cause immune-suppression, but should be better considered as an immune-modulating treatment. (C) 2011 Elsevier Ltd. All rights reserved.
Databáze: OpenAIRE